Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
AZD9574 selectively inhibits and traps PARP1. A, Chemical structure of ...
AZD9574 (Palacaparib) | PARP1 Inhibitor | CAS 2756333-39-6 | Selleck ...
RCSB PDB - 9ETR: Crystal structure of PARP1 catalytic domain bound to ...
Azd9574 – Application in Therapy and Current Clinical Research
AZD9574 - a PARP1 inhibitor for BRCA-mutant tumors - drug annotation ...
Study of AZD9574 and Temozolomide for Patients with Advanced Solid ...
Azd9574 | C21H22F2N6O2 | CID 162524593 - PubChem
AZD9574 for Advanced Solid Tumors Clinical Trial 2025 | Power
A Study of AZD9574 as Monotherapy and in Combination with Anti-Cancer ...
Abstract 2609: AZD9574 is a novel, brain penetrant PARP-1 selective ...
Study of AZD9574 as monotherapy and in combination with anti-cancer ...
Figure S1. Chemical structure of approved PARP-1 inhibitors. Downloaded ...
Figure S1. Chemical structure of approved PARP-1 inhibitors. | Download ...
RCSB PDB - 9ETQ: Crystal structure of PARP1 catalytic domain bound to ...
structure of protein pptx | PPTX
Protein Structure - Drug Design Org
Primary Structure Of Protein AlphaFold2 + ZINC20, Open A New Era Of
Structure of protein By KK Sahu Sir | PPT
恒瑞PARP1抑制剂出海带来的思考|抑制剂|首付款|实体瘤|恒瑞|专利|肿瘤|临床|-健康界
2022 AACR | 小分子领域：合成致死细化&PARP-1深度开发！__财经头条
Palacaparib (AZD9574, AZD-9574)| PARP1 inhibitor | Probechem Biochemicals
How does AstraZeneca's PARP inhibitor differentiate?
Discovery of 6-Fluoro-5-{4-[(5-fluoro-2-methyl-3-oxo-3,4 ...
Thread by @cenmag on Thread Reader App – Thread Reader App
ISSX 2022 - Hypha Discovery
Ambeed, Inc. on LinkedIn: #azd9574 #parp1 #ambeed #chemicals # ...
AZD-9574 is a potent and brain penetrant PARP1 inhibitor - Network of ...
谁能接班奥拉帕利？ - 知乎
AZD-9574 | PARP | TargetMol
十一月活性分子速递①: KT-474，RLY-2608，LY3522348与AZD9574 - 知乎
解析具有CNS渗透性的PARP1抑制剂AZD9574分子设计及优化过程 - 知乎
百亿美元市场！领路者阿斯利康两手抓：奥拉帕利再获新适应症，下一代产品多款布局
AZD5305 inhibits and traps selectively PARP1 in cells. A, Left ...
阿斯利康 B7-H4 ADC 国内临床即将启动！中国研发提速中_药物_Enhertu_研究
New drug candidates shine in San Diego
Computational Study on New Natural Compound Inhibitors of Pyruvate ...
AZD3759,CAS:1626387-80-1
AZ9482 is a Triple PARP1/2/6 Inhibitor - Network of Cancer Research
AZD9574(AZD9574) - 药物靶点：PARP1_在研适应症：晚期恶性实体瘤_专利_临床_研发
谁能接班奥拉帕利？_化合物_选择性_研究
Preclinical Characterization of AZD9574, a Blood–Brain Barrier ...
AstraZeneca Stock: What's Next? (Rating Downgrade) (NASDAQ:AZN ...
合成致死再添新星！这款PARP1抑制剂突破3个关键点医药新闻-ByDrug-一站式医药资源共享中心-医药魔方
Patent Analysis of Jiangsu Hengrui's PARP1 Inhibitor HRS-1167
A novel 18F-labeled brain penetrant PET ligand for imaging poly(ADP ...
阿斯利康第 2 款 PAPR1 高选择性抑制剂启动临床 6 月 14 日， 阿斯利康 在 ClinicalTrails.gov 上登记了 ...
AstraZeneca's second-generation PARP inhibitor AZD5305 is applied for ...
saruparib (AZD5305) / AstraZeneca
FDA撤销适应症，PARP下一步该怎么走？_奥拉帕利_临床_药物
XAV-939 | PARP 抑制剂 | 现货供应 | 美国品牌 | 免费采购电话400-668-6834
AZD 7594 – All About Drugs
Allosteric regulation of DNA binding and target residence time drive ...
PK/PD/efficacy relationship of AZD5305 in a BRCA1m TNBC xenograft tumor ...
In Silico Screening Identifies a Novel Potential PARP1 Inhibitor ...
PPAR | DC Chemicals
Discovery of Pyrazolo[1,5,4-de]quinoxalin-2(3H)-one Derivatives as ...
Synthesis and evaluation of 2‐(4‐[4‐acetylpiperazine‐1‐carbonyl] phenyl ...
Optimization of AZD1775-based analogues (adopted from Matheson et al ...
Clinical PARP inhibitors allosterically induce PARP2 retention on DNA ...
PARP抑制剂 | PARP Inhibitor
Privileged Scaffolds for Potent and Specific Inhibitors of Mono-ADP ...
Understanding Crystal Structures to Guide Form Selection of Active ...
Nicolas Dreyfus posted on LinkedIn
南通全益生物科技有限公司 -提供各类小分子剂定制合成，提供1000+库存
Drug Hunter - drug discovery, distilled
Targeting DNA damage response to enhance cancer immunotherapy efficacy ...
(A) Chemical structures of representative PARP-1 inhibitors. (B ...
Discovery of 5-{4-[(7-Ethyl-6-oxo-5,6-dihydro-1,5-naphthyridin-3-yl ...
Laying a trap to kill cancer cells: PARP inhibitors and their ...
DPP1 Inhibitors: First FDA Approval -China’s Fast-Follow Pipeline
Beyond PARP1 Single-Target Inhibitors–Combined Therapy Reveals More ...
Small Molecule Highlights #24 – April 2024 – Dalriada Drug Discovery
Advancements in Serine Protease Inhibitors: From Mechanistic Insights ...
卵巢癌新药有望提早获得FDA上市批准-美迪西生物医药
New Quinoxaline-Based Derivatives as PARP-1 Inhibitors: Design ...
Poly(ADP-Ribose) Polymerase (PARP) Inhibitors for Cancer Therapy ...
PARP1 Inhibitors: antitumor drug design - PMC
Structure-Based Pharmacophore Modeling, Virtual Screening, Molecular ...
Chemical structures of clinically used PARP inhibitors. The chemical ...
The Utility of In Vitro Data in Making Accurate Predictions of Human P ...
STEAP2靶点新突破：阿斯利康启动STEAP2 ADC1/2 期临床 2025年9月18日， 阿斯利康 （AstraZeneca）在 ...
The clinical development of inhibitors of poly(ADP-ribose) polymerase ...
Emerging Molecular PET Imaging for Cell Death in Neurodegenerative ...
The native (red) and predicted (blue) structures for two hairpin and ...
The PARP Inhibitor AZD2461 Provides Insights into the Role of PARP3 ...
The anticancer drugs in use and seven promising putative PARP-1 ...
Rapid route design of AZD7594 - Reaction Chemistry & Engineering (RSC ...
内卷加剧？PARP7前景如何？|抑制剂|内卷|临床|医药市场|-健康界
Efficacy and safety of AZD7594, an inhaled non-steroidal selective ...
Pharmacokinetic and Pharmacodynamic Evaluation of AZD5847 in a Mouse ...
